Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 3/20 | 0.32 |
| ▸ | HTR2C | P28335 | 2/20 | 0.32 |
| ▸ | HTR2B | P41595 | 2/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | CHUK | O15111 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20204869 | 0.88 | CHUK (0.34) | FABP4HTR2CHTR2BPDE4DCHUK | |
| SCHEMBL21324921 | 0.83 | HTR2C (0.34) | FABP4HTR2CHTR2BCNR2 | |
| SCHEMBL21324915 | 0.83 | HTR2C (0.34) | FABP4HTR2CHTR2BCNR2 | |
| SCHEMBL21533979 | 0.81 | HTR2C (0.33) | HTR2CHTR2BCNR2 | |
| SCHEMBL21533976 | 0.80 | HTR2C (0.33) | HTR2CHTR2BCNR2 | |
| SCHEMBL21690527 | 0.79 | HTR2C (0.33) | FABP4HTR2CHTR2BCNR2 | |
| SCHEMBL20207782 | 0.76 | APP (0.33) | FABP4HTR2CHTR2BPDE4DCNR2 | |
| SCHEMBL21324920 | 0.76 | HTR2C (0.35) | FABP4HTR2CHTR2BCNR2CHUK | |
| SCHEMBL20204868 | 0.76 | ADRA1A (0.40) | FABP4HTR2CHTR2BPDE4DCHUK | |
| SCHEMBL20207781 | 0.76 | ADRA1A (0.40) | FABP4HTR2CHTR2BPDE4DCHUK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018098207-A1 | HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | CV6 THERAPEUTICS (NI) LIMITED (GB) | 2018-05-31 | — | — | WO | disclosed |